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Margreet Lüchtenborg, Sharma P. Riaz, Victoria H. Coupland, Eric Lim, Erik Jakobsen, Mark Krasnik,
Richard Page, Michael J. Lind, Michael D. Peake, and Henrik Møller
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A B S T R A C T
Purpose
Studies have reported an association between hospital volume and survival for non–small-cell lung
cancer (NSCLC). We explored this association in England, accounting for case mix and propensity
to resect.
Methods
We analyzed data on 134,293 patients with NSCLC diagnosed in England between 2004 and 2008,
of whom 12,862 (9.6%) underwent surgical resection. Hospital volume was defined according to
number of patients with resected lung cancer in each hospital in each year of diagnosis. We
calculated hazard ratios (HRs) for death in three predefined periods according to hospital volume,
sex, age, socioeconomic deprivation, comorbidity, and propensity to resect.
Results
There was increased survival in hospitals performing  150 surgical resections compared with
those carrying out  70 (HR, 0.78; 95% CI, 0.67 to 0.90; Ptrend  .01). The association between
hospital volume and survival was present in all three periods of follow-up, but the magnitude of
association was greatest in the early postoperative period.
Conclusion
High-volume hospitals have higher resection rates and perform surgery among patients who are
older, have lower socioeconomic status, and have more comorbidities; despite this, they achieve
better survival, most notably in the early postoperative period.
J Clin Oncol 31:3141-3146. © 2013 by American Society of Clinical Oncology
INTRODUCTION
Non–small-cell lung cancer (NSCLC) accounts for
approximately 85% of all lung cancers. Surgical re-
section is the first-line treatment offered to patients
with early-stage disease who are considered medi-
cally fit.1
Many studies have shown that patients un-
dergoing surgery for lung cancer benefit from re-
ceiving treatment in hospitals where high
numbers of lung cancer resections are carried
out.2-13 Almost all of these studies were carried
out in the United States. In contrast, a number of
studies, for the most part carried out in countries
other than the United States, did not find an
association between hospital volume and out-
come after lung cancer resection.14-20 Some of
these were smaller studies.14,16,19 A recent meta-
analysis showed that increasing hospital volume
was associated with improved mortality in the
short term, but not with long-term survival.21 To
our knowledge, no study has been carried out to
assess the effect of hospital volume on survival
among patients with lung cancer in England.
Virtually all patients with lung cancer who
reach hospital care in England are managed by a
multidisciplinary team, with details of their cases
discussed in a structured meeting. There are 154
lung cancer multidisciplinary teams in England, and
almost all have a thoracic or cardiothoracic surgeon
in attendance. The surgery itself is mostly carried out
in a smaller number of specialist centers by specialist
thoracic or cardiothoracic surgeons. Our report ex-
plores the association between hospital volume and
survival among all patients with NSCLC diagnosed
in England who underwent surgical resection and
takes into account the differences in case selection
and propensity to resect.
METHODS
Patients
We extracted data on 161,737 lung cancers (Interna-
tional Classification of Diseases [version 10] codes C33 to
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C34) diagnosed in England between 2004 and 2008 from the National Cancer
Data Repository (NCDR). The NCDR contains data collected and quality
assured by the eight regional cancer registries in England. Death information is
supplied by the National Health Service (NHS) Central Register via the Office
for National Statistics. Information on surgical resections was obtained from
inpatient and day-case episodes recorded in the Hospital Episode Statistics
(HES) data set collated by the NHS Information Centre.
We excluded 7,547 lung cancers identified from death certificates only
and 358 cases without recorded NHS numbers. Only the first lung cancer
recorded for each patient was selected, which affected 573 patients with mul-
tiple primary lung cancers. Because they are rarely considered for surgical
resection, 18,966 patients (12.4%) with small-cell lung cancer were also ex-
cluded from analysis. The final data set thus included 134,293 patients with
NSCLC, of whom 12,862 (9.6%) underwent surgical resection in 58 NHS
hospital trusts.
Patient Characteristics
Information on surgery was derived from linked Hospital Episode Sta-
tistics (HES) records. Types of surgical resections were included as previously
defined22: lobectomy or bilobectomy (68%), partial lobectomy or wedge re-
section (16%), pneumonectomy (12%), sleeve resection (1%), and other less
common procedures (other or unspecified excisions of [or lesions of] trachea,
carina, lung, and chest wall, 4%). Data on surgery from 1 month before to 6
months after the date of diagnosis were included. If patients had  one record
of a relevant surgical procedure, the first procedure was used in analysis.
Socioeconomic deprivation was measured by lower super output area of
residence (each comprising a population of approximately 1,500) based on the
income domain of the Index of Deprivation 200723 and grouped into quintiles.
Each patient was thereby assigned to a socioeconomic quintile based on his or
her postcode of residence.
For each patient, comorbidity information was obtained using diagnosis
codes recorded in HES. All diagnoses from 2 years before to 3 months after the
patient’s date of diagnosis were classified according to scores from the
weighted Charlson comorbidity index24 and modified to exclude cancer as a
comorbid condition. The resulting scores were aggregated into four categories
of increasing severity of comorbidity.
Hospital Volume and Resection Quintile
The number of resections was available at the organization level of NHS
hospital trusts. In England, an NHS hospital trust manages  one local hospi-
tal. In this article, we refer to NHS hospital trusts simply as hospitals, and the
annual number of resections in an NHS hospital trust is referred to as the
hospital volume. Hospital volume was defined according to the number of
patients with lung cancer undergoing surgical resection in each hospital in
each year of diagnosis, which ranged from one to 194. Similar numbers of
resected patients were allocated to five hospital volume groups, which were
defined as follows:70, 70 to 99, 100 to 129, 130 to 149, and  150 procedures
per year (Table 1).
We created resection quintiles based on the proportion of patients with
lung cancer resident in each Primary Care Trust (PCT) geographic area who
underwent surgery by year of diagnosis, with quintile one representing PCT
areas where the lowest proportion of patients received surgery (5.5%) and
quintile five the highest (14.3%). Each patient with lung cancer was assigned to
a resection quintile, depending on his or her PCT area of residence.
Data Analysis
The number and proportions of patients who underwent surgical resec-
tion were calculated according to resection quintile and patient characteristics
(sex, age, socioeconomic deprivation, comorbidity, morphology, surgical pro-
cedure, and year of diagnosis). We also explored associations between hospital
volume and patient characteristics.
Cox proportional hazards regression analyses were used to assess the
association between hospital volume and survival among resected patients
(n  12,862). Survival time was calculated from date of surgery until date of
death resulting from any cause or end of study on December 31, 2009. We
calculated multivariable hazard ratios (HRs) according to hospital volume,
with appropriate adjustment for a priori identified potential confounders (sex,
age, socioeconomic deprivation, comorbidity, and resection quintile). In ad-
dition, to account for the risk of death potentially varying between groups of
patients treated within a given hospital, a shared frailty Cox model was used,
with hospital as a random effect. We estimated 2 and P values for trend or
heterogeneity, as appropriate, excluding the not-known categories. To assess
the association between hospital volume and survival in different time inter-
vals after surgery, the follow-up period was divided into three predefined
periods: perisurgical (0 to 30 days postsurgery), intermediate (31 to 365 days
postsurgery), and long term ( 365 days postsurgery).
Fit of the regression model was assessed with 2 tests and Harrell’s c
concordance statistic. We considered the assumption of proportional hazards
and explored the joint effects of independent variables by fitting first-order
interaction terms. All analyses were carried out using STATA (version 11.2;
STATA, College Station, TX).
RESULTS
An overview of the patients and proportions of patients undergoing
surgical resection included in the analysis is presented in Table 1. A
greater proportion of female patients underwent surgical resection
compared with male patients (9.9% v 9.4%; P .001). The proportion
of patients undergoing surgical resection decreased with advancing
age (P  .001). Increasing level of socioeconomic deprivation was
associated with a decreasing proportion of patients undergoing surgi-
cal resection (P  .001). Patients with more severe comorbidity were
less likely to undergo surgery (P  .001). We also assessed the associ-
ations between hospital volume and case-mix variables. There was a
positive association between hospital volume and resection quintile
(P  .001). Sex was not associated with hospital volume (P  .55).
Increasing hospital volume was associated with a higher proportion of
older patients undergoing surgery (P  .01). Higher-volume hospitals
included relatively greater numbers of patients from more-deprived
areas (P  .002) as well as relatively higher numbers of patients with
comorbidity (P  .001).
Table 2 lists the HRs as estimated by the sex- and age-adjusted
(model one), multivariable (model two), and multivariable shared-
frailty regression models (model three). After adjustment for age and
sex (model one), increasing hospital volume was associated with lower
mortality (2  7.08; Ptrend  .01). Compared with hospitals perform-
ing  70 surgical procedures per year, hospitals carrying out more
were all associated with decreased mortality, but the magnitude of the
association was similar in the range of hospital volume, from 70 to 149
procedures per year. Among hospitals carrying out  150 procedures
compared with those carrying out  70 per year, this association was
strongest (HR, 0.87; 95% CI, 0.80 to 0.95).
Further adjustment for socioeconomic deprivation, comorbid-
ity, and resection quintile (model two) strengthened the association
(2  12.77; Ptrend  .001), particularly in hospitals performing  150
surgical resections (HR, 0.83; 95% CI, 0.76 to 0.91). Using the shared-
frailty model to account for hospital-level variability in mortality
(model three) diminished the statistical significance of the association
(2  8.08; Ptrend  .01) but increased the absolute magnitude of the
association. For hospitals performing  150 surgical resections, HR
was 0.78 (95% CI, 0.67 to 0.90).
Table 3 lists fully adjusted (age, sex, socioeconomic deprivation,
comorbidity, and resection quintile) HRs estimated by the shared-
frailty model in the different time periods after surgery. Each of the
three periods of follow-up contributed to the overall association be-
tween hospital volume and survival (Table 2; model three), but the
linear trend in HRs did not reach statistical significance in all three
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periods. The extreme contrast between the lowest- and highest-
volume groups was statistically significant in all three periods of
follow-up. The magnitude of association was greatest in the period 0 to
30 days from surgery (HR for  150 hospital volume group compared
with  70, 0.58; 95% CI, 0.38 to 0.89) and smallest in the period 365
days after surgery (HR, 0.84; 95% CI, 0.71 to 0.99).
All variables in model three were statistically significant, and the
overall model had a 2 (23 df) of 476.5 (P  .001). Harrell’s c concor-
dance statistic was 0.59. First-order interaction terms added to model
three were not statistically significant.
DISCUSSION
In this study, we found that increasing hospital volume of lung cancer
surgical resection is associated with increased survival, particularly in
the early postoperative period. The association diminished but per-
sisted throughout follow-up.
We have previously shown that there is substantial geographic
variation in the proportion of patients with NSCLC who undergo
surgical resection and that increasing resection rates are associated
Table 1. Characteristics of Patients With NSCLC in England: 2004 to 2008
Characteristic Total No. of Patients
Resected
Patients Resection Volume (No. of procedures per year)
No. %  70 (%) 70 to 99 (%) 100 to 129 (%) 130 to 149 (%)  150 (%)
Total 134,293 12,862 9.6 2,582 2,662 2,378 2,651 2,589
No. of hospitals contributing to category 44 13 11 9 6
Resection quintile
1 26,970 1,483 5.5 14 12 14 12 6
2 26,800 2,041 7.6 16 22 15 16 11
3 26,824 2,517 9.4 21 19 18 24 16
4 26,990 3,011 11.2 25 20 29 26 18
5 26,709 3,810 14.3 26 27 25 22 48
2† 1,344.04 211.26
Ptrend  .001  .001
Sex
Male 78,221 7,317 9.4 57 56 58 57 56




0-54 8,878 1,395 15.7 12 11 11 10 10
55-59 9,595 1,417 14.8 12 11 11 11 10
60-64 14,721 2,138 14.5 16 16 16 17 17
65-69 18,654 2,502 13.4 19 18 20 21 19
70-74 22,389 2,605 11.6 20 21 19 21 20
75-79 25,382 2,006 7.9 15 16 16 16 16
80-84 20,652 697 3.4 5 6 6 4 7
 85 14,022 102 0.7 1 1 1 1 1
2† 3,212.91 7.54
Ptrend  .001 .01
Socioeconomic deprivation
1 (most affluent) 18,702 1,931 10.3 13 14 18 14 16
2 23,816 2,325 9.8 17 21 20 16 16
3 27,167 2,603 9.6 22 22 22 19 17
4 30,669 2,829 9.2 24 21 21 24 20
5 (most deprived) 33,939 3,174 9.4 24 23 19 27 31
2† 15.51 9.26
Ptrend  .001 .002
Charlson comorbidity score
0 64,013 6,840 10.7 53 57 59 50 49
1 36,618 4,250 11.6 34 32 28 36 35
2 13,129 1,175 8.9 9 8 9 9 11
 3 8,671 597 6.9 5 4 5 5 5
Not known 11,862 — — — — — — —
2† 92.77 24.06
Ptrend  .001  .001
Abbreviation: NSCLC, non–small-cell lung cancer.
Results given as %, except first two rows (ie, Total, No. of Hospitals Contributing to Category), which are presented as numbers.
†1 df.
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with increased survival.25 Adjustment for the propensity to operate in
the area of residence of the patient and for age, sex, socioeconomic
deprivation, and comorbidity strengthened the association between
hospital volume and survival. This indicates that hospital volume has
an independent effect on survival, irrespective of other factors that
affect the risk of dying. Interestingly, further adjustment for hospital-
level variation in mortality increased the magnitude of the association,
whereas statistical significance was attenuated because of the loss of
statistical power.
The significant trend in association between hospital volume and
survival is arguably a result of high mortality in the lowest hospital
volume group and low mortality in the highest volume group only. In
the three middle categories, representing hospital volumes ranging
from 70 to 149, there was little variation in survival (HRs were 0.86,
0.90, and 0.89, respectively). A fair narrative summary, therefore, may
be that low-volume hospitals have low survival, and high-volume
hospitals have high survival. We conducted a post hoc analysis com-
bining the three middle categories as the reference category and ob-
tained the following HRs:  70: HR, 1.14 (95% CI, 1.03 to 1.26); 70 to
149: HR, 1.00 (reference category); and  150: HR, 0.88 (95% CI, 0.79
to 0.97).
Hospital volume is a proxy measure, and it does not identify what
aspects of the practice of high-volume hospitals drive the observed
association with survival. Two potential explanations have been put
forward that could explain our results.26
Higher-volume hospitals may have more specialized infrastruc-
tures, are more likely to have dedicated thoracic surgery on site, and
could be expected to have advanced skills in the management of all
patients with lung cancer in all staff groups, which intuitively could
lead to higher survival.26 Higher hospital volumes may increase the
relevant experience and maintain the skills of surgeons in performing
complex lung cancer resections. They could also improve the skills of
the wider surgical team, including anesthetists, in managing postop-
erative complications in intensive care and high-dependency units,
which could lead to a reduction in early postoperative mortality. This
study found the biggest impact on survival in the early postoperative
period, suggesting in-hospital management as an important contrib-
utor to better outcomes. One study found a strong association be-
tween individual surgeon volume and in-hospital deaths.16 Other
research, however, has suggested that the association with hospital
volume may not be limited to surgeon experience alone, as illustrated
by a study that found that surgeon volume accounted for just 24% of
the observed association between lung cancer operative mortality and
hospital volume, whereas 34% of the association with surgeon volume
was explained by hospital volume.27 In addition, a UK study suggested
that individual surgeon volume per se was not associated with in-
hospital mortality.28
The observed associations may also be the result of referral pat-
terns (ie, larger surgical volumes are result of better outcomes) rather
than the cause.26 Some hospitals have more skillful surgeons and
Table 2. HRs and 95% CIs According to Hospital Volume Among Patients With NSCLC
Hospital Volume (No. of procedures per year)
Model One Model Two† Model Three‡
HR 95% CI HR 95% CI HR 95% CI
 70 1.00 — 1.00 — 1.00 —
70 to 99 0.89 0.82 to 0.97 0.90 0.83 to 0.98 0.86 0.77 to 0.97
100 to 129 0.92 0.84 to 1.00 0.93 0.85 to 1.01 0.90 0.79 to 1.02
130 to 149 0.91 0.84 to 0.99 0.91 0.83 to 0.98 0.89 0.78 to 1.02
 150 0.87 0.80 to 0.95 0.83 0.76 to 0.91 0.78 0.67 to 0.90
2§ 7.08 12.77 8.08
P  .01  .001  .01
Abbreviations: HR, hazard ratio; NSCLC, non–small-cell lung cancer.
Adjusted for age and sex.
†Adjusted for age, sex, socioeconomic deprivation, Charlson comorbidity score, and resection quintile.
‡Shared-frailty model adjusted for age, sex, socioeconomic deprivation, Charlson comorbidity score, resection quintile, and hospital (random effect).
§1 df.
Table 3. HRs and 95% CIs According to Hospital Volume Among Patients With NSCLC by Period of Follow-Up
Hospital Volume (No. of procedures per year)
0 to 30 Days 31 to 365 Days  365 Days
HR 95% CI HR 95% CI HR 95% CI
 70 1.00 — 1.00 — 1.00 —
70 to 99 0.81 0.58 to 1.13 0.82 0.70 to 0.96 0.95 0.83 to 1.09
100 to 129 0.75 0.52 to 1.08 0.92 0.78 to 1.09 0.94 0.81 to 1.08
130 to 149 0.91 0.64 to 1.31 0.78 0.66 to 0.93 0.97 0.84 to 1.13
 150 0.58 0.38 to 0.89 0.80 0.67 to 0.95 0.84 0.71 to 0.99
2 3.24 5.93 2.67
P .07 .01 .10
NOTE. Based on shared-frailty model adjusted for age, sex, socioeconomic deprivation, Charlson comorbidity score, resection quintile, and hospital (random effect).
Abbreviations: HR, hazard ratio; NSCLC, non–small-cell lung cancer.
1 df.
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multidisciplinary teams and better equipment and, as a result, may
attract a larger number of patients with NSCLC who would undergo
surgical resection. Moreover, high-volume hospitals may employ bet-
ter methods for accurate staging and select patients with better fitness
and stage distribution. However, the data presented here show that
higher-volume hospitals achieve better outcomes despite performing
surgery among older patients with greater comorbidity and from
lower socioeconomic backgrounds. This argues against selective refer-
ral of a more favorable patient population.
The findings in this study are in agreement with a number of
studies that also observed better survival among patients with resected
lung cancer with increasing hospital volume.2-11 Moreover, we and
others have shown similar effects in other types of cancer.3,4,7-9,11-13,29
Postoperative mortality HRs were found to be of the same order of
magnitude as previously published fatality odds ratios.2,10 The
magnitude of association between hospital volume and survival in
this study was similar to those observed in three studies reporting
similar measures.2,4,6
This study benefits from nationwide data on patients undergoing
surgical resection in England. The NCDR case ascertainment for lung
cancer is estimated to be high, at approximately 99%.30 HES holds
detailed records of admitted patient care delivered in England by NHS
hospitals or delivered in the independent sector but commissioned by
the NHS. A systematic review found acceptable accuracy for proce-
dure codes from NHS administrative data.31 We adjusted the survival
analysis for potential confounding by age, sex, socioeconomic depri-
vation, comorbidity, and propensity to operate in the area where the
patient was diagnosed, which strengthened the observed associations.
However, a major limitation of the present study is the absence of data
on staging procedures, pre- and postoperative stages, and treatments
other than surgery. Although one explanation for the results is that
lower-volume hospitals are performing surgery among patients
with more-advanced tumors (perhaps as a result of less detailed
preoperative staging [eg, because of poor access to positron emis-
sion tomography– computed tomography scanning and endo-
scopic ultrasound]), leading to poorer long-term survival, this
concern is mitigated by higher-volume hospitals having a higher
surgical resection rate. It is thus more likely that the higher-volume
hospitals are extending rather than reducing the boundaries of
resectability among the patients they manage.
In conclusion, our results indicate that hospitals in England with
high volumes of surgical resection of lung cancer perform surgery
among patients who are older, are more socioeconomically deprived,
and have more comorbidity. Despite this, they achieve better survival,
especially in the early postoperative period.
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al: Hospital volume, proportion resected and
mortality from oesophageal and gastric cancer: A
population-based study in England, 2004-2008. Gut
62:961-966, 2013
30. Møller H, Richards S, Hanchett N, et al: Com-
pleteness of case ascertainment and survival time
error in English cancer registries: Impact on 1-year
survival estimates. Br J Cancer 105:170-176, 2011
31. Burns EM, Rigby E, Mamidanna R, et al:
Systematic review of discharge coding accuracy. J
Public Health (Oxf) 34:138-148, 2012
■ ■ ■
Simplify Your Search With JCO Subject Collections
Subject Collections are topic-specific archives of articles published on jco.org that make it easy for you to find the research
you need. Instead of random, time-consuming keyword searches, JCO Subject Collections allow you to quickly browse
your interest areas for articles on specific diseases and treatments. Best of all, by signing up for Collection Alerts, you’ll
receive e-mail notification whenever JCO publishes an article in your interest area.
Sign up today at jco.org/collections.
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Appendix
Research in Context
We reviewed evidence on the association between hospital surgical volume and lung cancer survival and mortality. We searched
peer-reviewed publications using PubMed. We used different combinations of the terms lung cancer, surgery, resection, lobectomy,
pneumonectomy, hospital volume, surgical volume, survival, and mortality. After initial identification of relevant articles, the referenced
reports listed in those were also searched, as were articles indicated as related by PubMed.
Interpretation
Numerous studies, predominantly carried out in the United States, have shown that patients undergoing surgery for lung cancer
benefit from receiving treatment in hospitals where high numbers of lung cancer resections are carried out.2-13 However, a number of
studies, for the most part carried out in countries other than the United States, and some based on smaller numbers of patients, did not find
an association between hospital volume and outcome after lung cancer resection.14-20 A recent meta-analysis showed that higher hospital
volume was associated with improved mortality in the short term, but not with long-term survival.21
This study is the first to our knowledge to assess the relationship between hospital surgical volume and lung cancer survival in
England. Moreover, this large national study over a 5-year period allowed for the investigation of both short- and long-term survival
outcomes among patients with non–small-cell lung cancer across a wide range of hospital volumes. The results presented in our report
indicate that hospitals in England with high volumes of surgical resection of lung cancer perform surgery among patients who are older,
are more socioeconomically deprived, and have more comorbidity and, despite this, achieve better survival, especially in the early
postoperative period. These findings would encourage centralization of lung cancer surgery.
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